RNA toxicity in non‐coding repeat expansion disorders

por Swinnen, Bart, Robberecht, Wim, Van Den Bosch, Ludo
Publicado 2019

Modelling amyotrophic lateral sclerosis: progress and possibilities

por Van Damme, Philip, Robberecht, Wim, Van Den Bosch, Ludo
Publicado 2017

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

por Pollari, Eveliina, Prior, Robert, Robberecht, Wim, Van Damme, Philip, Van Den Bosch, Ludo
Publicado 2018

Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice

por Herdewyn, Sarah, Cirillo, Carla, Van Den Bosch, Ludo, Robberecht, Wim, Vanden Berghe, Pieter, Van Damme, Philip
Publicado 2014

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease

por Benoy, Veronick, Vanden Berghe, Pieter, Jarpe, Matthew, Van Damme, Philip, Robberecht, Wim, Van Den Bosch, Ludo
Publicado 2016

Conditional deletion of Id2 or Notch1 in oligodendrocyte progenitor cells does not ameliorate disease outcome in SOD1(G93A) mice

por Eykens, Caroline, Nonneman, Annelies, Jensen, Cathy, Iavarone, Antonio, Van Damme, Philip, Van Den Bosch, Ludo, Robberecht, Wim
Publicado 2018

Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy

por Laird, Angela S., Van Hoecke, Annelies, De Muynck, Louis, Timmers, Mieke, Van Den Bosch, Ludo, Van Damme, Philip, Robberecht, Wim
Publicado 2010

FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins

por Steyaert, Jolien, Scheveneels, Wendy, Vanneste, Joni, Van Damme, Philip, Robberecht, Wim, Callaerts, Patrick, Bogaert, Elke, Van Den Bosch, Ludo
Publicado 2018

Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study

por Hermans, Greet, Schrooten, Maarten, Van Damme, Philip, Berends, Noor, Bouckaert, Bernard, De Vooght, Wouter, Robberecht, Wim, Berghe, Greet Van den
Publicado 2009

Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo

por Beel, Sander, Moisse, Matthieu, Damme, Markus, De Muynck, Louis, Robberecht, Wim, Van Den Bosch, Ludo, Saftig, Paul, Van Damme, Philip
Publicado 2017

Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice

por Beel, Sander, Herdewyn, Sarah, Fazal, Raheem, De Decker, Mathias, Moisse, Matthieu, Robberecht, Wim, Van Den Bosch, Ludo, Van Damme, Philip
Publicado 2018

Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy

por de Boer, Antina, Storm, Annet, Gomez-Soler, Maricel, Smolders, Silke, Rué, Laura, Poppe, Lindsay, B Pasquale, Elena, Robberecht, Wim, Lemmens, Robin
Publicado 2020

Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis

por Staats, Kim A., Schönefeldt, Susann, Van Rillaer, Marike, Van Hoecke, Annelies, Van Damme, Philip, Robberecht, Wim, Liston, Adrian, Van Den Bosch, Ludo
Publicado 2013

Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival

por Van Damme, Philip, Van Hoecke, Annelies, Lambrechts, Diether, Vanacker, Peter, Bogaert, Elke, van Swieten, John, Carmeliet, Peter, Van Den Bosch, Ludo, Robberecht, Wim
Publicado 2008

Rapamycin increases survival in ALS mice lacking mature lymphocytes

por Staats, Kim A, Hernandez, Sara, Schönefeldt, Susann, Bento-Abreu, André, Dooley, James, Van Damme, Philip, Liston, Adrian, Robberecht, Wim, Van Den Bosch, Ludo
Publicado 2013

Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis

por Rué, Laura, Timmers, Mieke, Lenaerts, Annette, Smolders, Silke, Poppe, Lindsay, de Boer, Antina, Van Den Bosch, Ludo, Van Damme, Philip, Robberecht, Wim, Lemmens, Robin
Publicado 2019

Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy

por Poppe, Lindsay, Smolders, Silke, Rué, Laura, Timmers, Mieke, Lenaerts, Annette, Storm, Annet, Schoonaert, Lies, de Boer, Antina, Van Damme, Philip, Van Den Bosch, Ludo, Robberecht, Wim, Lemmens, Robin
Publicado 2019

Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis

por Herdewyn, Sarah, Zhao, Hui, Moisse, Matthieu, Race, Valérie, Matthijs, Gert, Reumers, Joke, Kusters, Benno, Schelhaas, Helenius J., van den Berg, Leonard H., Goris, An, Robberecht, Wim, Lambrechts, Diether, Van Damme, Philip
Publicado 2012

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA stu...

por Léger, Jean-Marc, De Bleecker, Jan L, Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Shebl, Amgad, Bauhofer, Artur, Zenker, Othmar, Merkies, Ingemar S J
Publicado 2013

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

por Merkies, Ingemar S. J., Lawo, John‐Philip, Edelman, Jonathan M., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Léger, Jean‐Marc
Publicado 2017